These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16175004)

  • 1. Low-density lipoprotein receptor-related protein polymorphisms in patients with elevated factor VIII coagulant activity and venous thrombosis.
    Cunningham N; Laffan MA; Manning RA; O'Donnell JS
    Blood Coagul Fibrinolysis; 2005 Oct; 16(7):465-8. PubMed ID: 16175004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-density lipoprotein receptor-related protein 1 polymorphism 663 C > T affects clotting factor VIII activity and increases the risk of venous thromboembolism.
    Vormittag R; Bencur P; Ay C; Tengler T; Vukovich T; Quehenberger P; Mannhalter C; Pabinger I
    J Thromb Haemost; 2007 Mar; 5(3):497-502. PubMed ID: 17155964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variations in sites of affinity between FVIII and LRP1 are not associated with high FVIII levels in venous thromboembolism.
    Bittar LF; Siqueira LH; Orsi FA; De Paula EV; Annichino-Bizzacchi JM
    Sci Rep; 2015 Mar; 5():9246. PubMed ID: 25782371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological and genetic factors influencing plasma factor VIII levels in a healthy family population: results from the Stanislas cohort.
    Morange PE; Tregouet DA; Frere C; Saut N; Pellegrina L; Alessi MC; Visvikis S; Tiret L; Juhan-Vague I
    Br J Haematol; 2005 Jan; 128(1):91-9. PubMed ID: 15606554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low density lipoprotein receptor-related protein polymorphisms are not risk factors for venous thromboembolism.
    Mello TB; Siqueira LH; Montavão SA; Ozello MC; Annichino-Bizzacchi JM
    Thromb Res; 2008; 121(5):625-9. PubMed ID: 17889283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence That Factor VIII Forms a Bivalent Complex with the Low Density Lipoprotein (LDL) Receptor-related Protein 1 (LRP1): IDENTIFICATION OF CLUSTER IV ON LRP1 AS THE MAJOR BINDING SITE.
    Young PA; Migliorini M; Strickland DK
    J Biol Chem; 2016 Dec; 291(50):26035-26044. PubMed ID: 27794518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marked elevation of thrombin generation in patients with elevated FVIII:C and venous thromboembolism.
    O'Donnell J; Mumford AD; Manning RA; Laffan MA
    Br J Haematol; 2001 Dec; 115(3):687-91. PubMed ID: 11736955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-adrenergic receptor polymorphisms in patients with elevated factor VIII levels with venous thrombosis.
    O'Donnell J; Manning RA; Laffan MA
    Br J Haematol; 2003 Oct; 123(1):139-41. PubMed ID: 14510956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A common polymorphism decreases LRP1 mRNA stability and is associated with increased plasma factor VIII levels.
    Lee JD; Hsiao KM; Chang PJ; Chen CC; Kuo YW; Huang YC; Hsu HL; Lin YH; Wu CY; Huang YC; Lee M; Hsu CY; Pan YT; Kuo CY; Lin CH
    Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1690-1698. PubMed ID: 28431990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High factor VIII (FVIII) levels in venous thromboembolism: role of unbound FVIII.
    Schambeck CM; Grossmann R; Zonnur S; Berger M; Teuchert K; Spahn A; Walter U
    Thromb Haemost; 2004 Jul; 92(1):42-6. PubMed ID: 15213843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of interaction between blood coagulation factor VIII and LRP1 suggests dynamic binding by alternating complex contacts.
    Chun H; Kurasawa JH; Olivares P; Marakasova ES; Shestopal SA; Hassink GU; Karnaukhova E; Migliorini M; Obi JO; Smith AK; Wintrode PL; Durai P; Park K; Deredge D; Strickland DK; Sarafanov AG
    J Thromb Haemost; 2022 Oct; 20(10):2255-2269. PubMed ID: 35810466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parameters influencing FVIII pharmacokinetics in patients with severe and moderate haemophilia A.
    Kepa S; Horvath B; Reitter-Pfoertner S; Schemper M; Quehenberger P; Grundbichler M; Heistinger M; Neumeister P; Mannhalter C; Pabinger I
    Haemophilia; 2015 May; 21(3):343-350. PubMed ID: 25582282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated factor VIII levels and risk of venous thrombosis.
    Jenkins PV; Rawley O; Smith OP; O'Donnell JS
    Br J Haematol; 2012 Jun; 157(6):653-63. PubMed ID: 22530883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-receptor blockade decreases elevated plasma levels of factor VIII:C in patients with deep vein thrombosis.
    Hoppener MR; Kraaijenhagen RA; Hutten BA; Büller HR; Peters RJ; Levi M
    J Thromb Haemost; 2004 Aug; 2(8):1316-20. PubMed ID: 15304037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma factor VIII in non-puerperal cerebral venous thrombosis: a prospective case-control study.
    Anadure RK; Nagaraja D; Christopher R
    J Neurol Sci; 2014 Apr; 339(1-2):140-3. PubMed ID: 24560376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-density lipoprotein receptor-related protein-1: role in the regulation of vascular integrity.
    Strickland DK; Au DT; Cunfer P; Muratoglu SC
    Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):487-98. PubMed ID: 24504736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor VIII Interacts with the Endocytic Receptor Low-density Lipoprotein Receptor-related Protein 1 via an Extended Surface Comprising "Hot-Spot" Lysine Residues.
    van den Biggelaar M; Madsen JJ; Faber JH; Zuurveld MG; van der Zwaan C; Olsen OH; Stennicke HR; Mertens K; Meijer AB
    J Biol Chem; 2015 Jul; 290(27):16463-76. PubMed ID: 25903134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms and mutations in vWF and ADAMTS13 genes and their correlation with plasma levels of FVIII and vWF in patients with deep venous thrombosis.
    Bittar LF; de Paula EV; Mello TB; Siqueira LH; Orsi FL; Annichino-Bizzacchi JM
    Clin Appl Thromb Hemost; 2011 Oct; 17(5):514-8. PubMed ID: 20682599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular uptake of coagulation factor VIII: Elusive role of the membrane-binding spikes in the C1 domain.
    Castro-Núñez L; Koornneef JM; Rondaij MG; Bloem E; van der Zwaan C; Mertens K; Meijer AB; Meems H
    Int J Biochem Cell Biol; 2017 Aug; 89():34-41. PubMed ID: 28558995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated levels of factor VIII and subsequent risk of all-cause mortality: results from the MEGA follow-up study.
    Yap ES; Timp JF; Flinterman LE; van Hylckama Vlieg A; Rosendaal FR; Cannegieter SC; Lijfering WM
    J Thromb Haemost; 2015 Oct; 13(10):1833-42. PubMed ID: 26264493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.